Laboratory of Teaching of Prevention and Control of Healthcare-Associated Infections, Federal Fluminense University, Rio de Janeiro, Brazil.
Laboratory of Teaching of Prevention and Control of Healthcare-Associated Infections, Federal Fluminense University, Rio de Janeiro, Brazil.
J Hosp Infect. 2018 Jun;99(2):117-123. doi: 10.1016/j.jhin.2017.08.003. Epub 2017 Aug 12.
The United Nations and the World Health Organization have designated antimicrobial resistance (AMR) as a major health priority and developed action plans to reduce AMR in all healthcare settings. Establishment of institutional antimicrobial stewardship programmes (ASPs) is advocated as a key intervention to reduce antibiotic consumption in hospitals and address high rates of multi-drug-resistant (MDR) bacteria. PUBMED and the Cochrane Database of Systematic Reviews (January 2007-March 2017) were searched to identify studies reporting the effectiveness of ASPs in general paediatric wards and paediatric intensive care units (PICUs) for reducing antibiotic consumption, use of broad-spectrum/restricted antibiotics, and antibiotic resistance and healthcare-associated infections (HAIs). Neonatal units and antifungal agents were excluded. Of 2509 titles and abstracts, nine articles were eligible for inclusion in the final analysis. All studies reported a reduction in the use of broad-spectrum/restricted antibiotics or antibiotic consumption. One study reported a reduction in HAIs in a PICU, and another study evaluated bacterial resistance, showing no effect following ASP implementation. Prospective audit on antibiotic use was the most common ASP core component (eight of nine studies). Antibiotic pre-authorization was described in two studies. Other described interventions were the provision of guidelines or written information (five of nine studies), and training of healthcare professionals (one study). There is limited evidence for a reduction in antibiotic consumption and use of broad-spectrum/restricted agents following ASP implementation specifically in PICUs. Data evaluating the impact of ASPs on HAIs and AMR in PICUs are lacking. In addition, there is limited information on effective components of a successful ASP in PICUs.
联合国和世界卫生组织已将抗微生物药物耐药性(AMR)指定为一项主要卫生重点,并制定了行动计划,以减少所有医疗保健环境中的 AMR。建立机构性抗微生物药物管理计划(ASPs)被认为是减少医院抗生素使用和解决高多重耐药(MDR)细菌率的关键干预措施。检索了 PUBMED 和考科蓝系统评价数据库(2007 年 1 月至 2017 年 3 月),以确定报告 ASP 在普通儿科病房和儿科重症监护病房(PICU)中降低抗生素消耗、使用广谱/限制使用抗生素以及抗生素耐药性和与医疗保健相关感染(HAIs)的有效性的研究。排除新生儿病房和抗真菌药物。在 2509 个标题和摘要中,有 9 篇文章符合最终分析的条件。所有研究均报告广谱/限制使用抗生素或抗生素消耗减少。一项研究报告称,在 PICU 中降低了 HAI 的发生率,另一项研究评估了细菌耐药性,在实施 ASP 后没有显示出效果。抗生素使用的前瞻性审核是最常见的 ASP 核心组成部分(9 项研究中的 8 项)。有两项研究描述了抗生素预授权。其他描述的干预措施包括提供指南或书面信息(9 项研究中的 5 项)和培训医疗保健专业人员(1 项研究)。有有限的证据表明,在实施 ASP 后,PICU 中的抗生素消耗和广谱/限制使用剂的使用减少。关于 ASP 对 PICU 中 HAI 和 AMR 的影响的数据缺乏。此外,关于 PICU 中成功 ASP 的有效组成部分的信息有限。